BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16438939)

  • 61. [Pharmacological studies on hinokitiol (4-isopropyl tropolone)].
    KATSURA S
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1954; 221(3):215-8. PubMed ID: 13165735
    [No Abstract]   [Full Text] [Related]  

  • 62. Metal complexes with tropolones.
    Dutt Y; Singh RP; Katyal M
    Talanta; 1969 Oct; 16(10):1369-82. PubMed ID: 18960644
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Efficacy and cytotoxicity in cell culture of novel α-hydroxytropolone inhibitors of hepatitis B virus ribonuclease H.
    Lomonosova E; Daw J; Garimallaprabhakaran AK; Agyemang NB; Ashani Y; Murelli RP; Tavis JE
    Antiviral Res; 2017 Aug; 144():164-172. PubMed ID: 28633989
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hepatitis C virus NS3 inhibitors: current and future perspectives.
    Salam KA; Akimitsu N
    Biomed Res Int; 2013; 2013():467869. PubMed ID: 24282816
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antiviral therapy for hepatitis C virus: beyond the standard of care.
    Delang L; Coelmont L; Neyts J
    Viruses; 2010 Apr; 2(4):826-866. PubMed ID: 21994657
    [TBL] [Abstract][Full Text] [Related]  

  • 66. New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agents.
    Quer J; Buti M; Cubero M; Guardia J; Esteban R; Esteban JI
    Infect Drug Resist; 2010; 3():133-45. PubMed ID: 21694902
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dicarbon-yl[2-hydr-oxy-3,5,7-tris-(mor-pho-linomethyl)cyclo-hepta-2,4,6-trien-onato(1-)-κO,O]rhodium(I).
    Hill TN; Steyl G
    Acta Crystallogr Sect E Struct Rep Online; 2008 Nov; 64(Pt 12):m1580-1. PubMed ID: 21581182
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Helicase inhibitors as specifically targeted antiviral therapy for hepatitis C.
    Belon CA; Frick DN
    Future Virol; 2009 May; 4(3):277-293. PubMed ID: 20161209
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Monitoring helicase activity with molecular beacons.
    Belon CA; Frick DN
    Biotechniques; 2008 Oct; 45(4):433-40, 442. PubMed ID: 18855770
    [TBL] [Abstract][Full Text] [Related]  

  • 70. NS3 Peptide, a novel potent hepatitis C virus NS3 helicase inhibitor: its mechanism of action and antiviral activity in the replicon system.
    Gozdek A; Zhukov I; Polkowska A; Poznanski J; Stankiewicz-Drogon A; Pawlowicz JM; Zagórski-Ostoja W; Borowski P; Boguszewska-Chachulska AM
    Antimicrob Agents Chemother; 2008 Feb; 52(2):393-401. PubMed ID: 18039921
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Step-by-step progress toward understanding the hepatitis C virus RNA helicase.
    Frick DN
    Hepatology; 2006 Jun; 43(6):1392-5. PubMed ID: 16729317
    [TBL] [Abstract][Full Text] [Related]  

  • 72. New acridone-4-carboxylic acid derivatives as potential inhibitors of hepatitis C virus infection.
    Stankiewicz-Drogon A; Palchykovska LG; Kostina VG; Alexeeva IV; Shved AD; Boguszewska-Chachulska AM
    Bioorg Med Chem; 2008 Oct; 16(19):8846-52. PubMed ID: 18801660
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chemical genetics approach to hepatitis C virus replication: cyclophilin as a target for anti-hepatitis C virus strategy.
    Watashi K; Shimotohno K
    Rev Med Virol; 2007; 17(4):245-52. PubMed ID: 17299803
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evaluation systems for anti-HCV drugs.
    Moriishi K; Matsuura Y
    Adv Drug Deliv Rev; 2007 Oct; 59(12):1213-21. PubMed ID: 17720275
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Searching for a new anti-HCV therapy: synthesis and properties of tropolone derivatives.
    Boguszewska-Chachulska AM; Krawczyk M; Najda A; Kopańska K; Stankiewicz-Drogoń A; Zagórski-Ostoja W; Bretner M
    Biochem Biophys Res Commun; 2006 Mar; 341(2):641-7. PubMed ID: 16438939
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Studies on the anti-hepatitis C virus activity of newly synthesized tropolone derivatives: identification of NS3 helicase inhibitors that specifically inhibit subgenomic HCV replication.
    Najda-Bernatowicz A; Krawczyk M; Stankiewicz-Drogoń A; Bretner M; Boguszewska-Chachulska AM
    Bioorg Med Chem; 2010 Jul; 18(14):5129-36. PubMed ID: 20579888
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Synthesis and anti-HCV activity evaluation of anilinoquinoline derivatives.
    Peng HK; Lin CK; Yang SY; Tseng CK; Tzeng CC; Lee JC; Yang SC
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1107-10. PubMed ID: 22204909
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.